JPRN-UMIN000039425
Recruiting
未知
The observational study to investigate serum carnitine level for patients who will receive HCC treatments and liver transplantation - The observational study to investigate serum carnitine level for patients who will receive HCC treatments and liver transplantation
Kobe University Graduate School of Medicine0 sites200 target enrollmentFebruary 7, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hepatocellular carcinoma Liver transplantation
- Sponsor
- Kobe University Graduate School of Medicine
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients whom the principal investigator judged as inappropriate for the participation of the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical study to assess response of a drug that treats low red blood cells count in chronic kidney disease patientsHealth Condition 1: N183- Chronic kidney disease, stage 3 (moderate)Health Condition 2: N184- Chronic kidney disease, stage 4 (severe)Health Condition 3: N185- Chronic kidney disease, stage 5Health Condition 4: N186- End stage renal diseaseCTRI/2024/01/060994BHAWNA SAINI
Completed
Not Applicable
Clinical Study using serum samples obtained in clinical trial of absorbed influenza vaccine(2)side effect of influenza vaccineJPRN-UMIN000018479ational Institutes of Biomedical Innovation,Health and Nutrition150
Completed
Not Applicable
Clinical Study using serum samples obtained in clinical trial of absorbed influenza vaccineside effect of influenza vaccineJPRN-UMIN000013074ational Institutes of Biomedical Innovation,Health and Nutrition30
Completed
Not Applicable
Clinical study using preserved serum samples obtained in clinical trials of absorbed influenza vaccine (H5N1).H5N1 influenzaJPRN-jRCT1090220048ational Hospital Organization Mie National Hospital350
Active, not recruiting
Not Applicable
/AFor at evaluere sikkerheden og muligheden for dosisoptimering ved topisk administreret ropivacain, ønsker vi at måle serumkoncentrationen af lægemidlet i blodprøver fra patienter, der behandles med gentagne bolusinjektioner med ropivacain som postoperativ smertebehandling efter osteosyntese (operation med skruer og skinner) af hoftenært lårbensbrud af pertrochantær type.MedDRA version: 9.1Level: LLTClassification code 10034736Term: Pertrochanteric fracture of femur, closedEUCTR2009-013396-22-DKOdense Universitetshospital/Syddansk Universitet25